We are monitoring the impact of COVID-19 on North America Regenerative Medicines Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 241
Share on
Share on

North America Regenerative Medicines Market Research Report – Segmented By Product, By Therapy, By Application & By Country (US, Canada and Rest of North America) – Size, Share, Trends, Growth, Forecast | 2019 - 2024

Pulished: August, 2019
ID: 241
Pages: 145

North America Regenerative Medicines Market Size & Growth (2019 - 2024)

The Regenerative Medicines Market worth in North America is expected to reach USD 13.67 billion by 2024 from USD 5.38 billion in 2019, growing at a CAGR of 20.50% during the forecast period 2019-2024.

The significant drivers that are boosting the growth of North America regenerative medicine market are rising incidence of bone and joint diseases, growing awareness among population, emergence of advanced technologies in tissue engineering and stem cell therapy, rise in demand for regenerative medicines in treatment of chronic diseases, cancer, and orthopedic disorders, enhancements in nanotechnology, and rise in adoption of CAR-T therapies. 

The factors that are diminishing the growth of the North America regenerative medicine market are side effects associated with implantation, stringent rules for using human tissues, treatment is highly expensive, growing adoption of cell-based products like stem cells, regulations, and policies on regenerative medicines.

The North America Regenerative medicine market is expected to expand at high pace owing to significant growth opportunities such as increased efforts of researchers to develop regenerative medicines owing to unavailability of organs for transplantation, increasing investments in R & D for developing innovative products, major competitors and research institutes of the market are likely to release a wide range of products in gene therapy and stem cells during the forecast period, potential risks like organ damage or failed functionality that are involved in transplanting organs traditionally, is leading to rising in acceptance of regenerative medicine for transplanting organs.

This research report segmented and sub-segmented into the following categories:

  • By Product: Cell-Based Products, Acellular Products
  • By Therapy: Cell Therapy, Gene Therapy, Tissue Engineering, and Immunotherapy
  • By Application: Orthopedic & Musculoskeletal Spine, Dermatology, Cardiovascular, Central Nervous System, Oncology, Diabetes, and Other Application
  • By Country: US, Canada and Rest of North America

On the basis of geographical areas, North America regenerative medicine market is dominating the global market by contributing largest share of revenue owing to market catalyzing factors such as growing awareness of personalized medicine and emergence of CAR-T cell therapies, increase in investments for developing innovative regenerative medicines, US contributes major share among all of the North American countries owing to presence of significant market players and research institutes that are developing innovative techniques and availability of high-end technology whereas Canada is estimated to grow at a higher CAGR during the forecast period.

Promising companies leading the North American Regenerative Medicines Market profiled in this report are Vertex Pharmaceuticals Incorporated, Acelity L.P. Inc., Celgene Corporation, StemCells, Inc., Organogenesis Inc., NuVasive, Inc., Vericel Corporation (Genzyme), Japan Tissue Engineering Co., Ltd.,  Cytori Therapeutics Inc., Advantagene, Inc. and Mesoblast Ltd.

1. Introduction                                                                                 

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                          

                1.4 General Study Assumptions                                                                

2. Research Methodology                                                                                           

                2.1 Introduction                                                                               

                2.2 Research Phases                                                                      

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design                                                                         

                2.4 Study Timeline                                                                          

3. Overview                                                                                       

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 New Developments                                                                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                                    

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                                              

5. Market Segmentation                                                                                              

                5.1 Introduction                                                                               

                5.2 Product                                                                        

                                5.2.1 Introduction                                                           

                                5.2.2 Cell-Based Products                                                            

                                                5.2.2.1 Autologous Cell-Based Products                                

                                                5.2.2.2 Allogeneic Cell-Based Products                                  

                                5.2.3 Acellular Products                                                

                5.3 Therapy                                                                       

                                5.3.1 Introduction                                                           

                                5.3.2 Cell Therapy                                                           

                                5.3.3 Gene Therapy                                                       

                                5.3.4 Tissue Engineering                                                               

                                5.3.5 Immunotherapy                                                   

                5.4 Application                                                                 

                                5.4.1 Introduction                                                           

                                5.4.2 Orthopedic & Musculoskeletal Spine                                                           

                                5.4.3 Dermatology                                                          

                                5.4.4 Cardiovascular                                                       

                                5.4.5 Central Nervous System                                                   

                                5.4.6 Oncology                                                 

                                5.4.7 Diabetes                                                  

                                5.4.8 Other Applications                                                               

6. Geographical Analysis                                                                                              

                                6.1 Introduction                                                               

                                6.2 United States                                                            

                                6.3 Canada                                                         

7. Strategic Analysis                                                                                       

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

8. Market Leaders' Analysis                                                                                        

                8.1 Vertex Pharmaceuticals Incorporated (U.S.)                                                                

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Strategic Evaluation and Operations                                                            

                                8.1.4 Financial analysis                                                  

                                8.1.5 Legal issues                                                             

                                8.1.6 Recent Developments                                                       

                                8.1.7 SWOT analysis                                                       

                                8.1.8 Analyst View                                                          

                8.2 Acelity L.P. Inc. (U.S.)                                                                             

                8.3 Celgene Corporation (U.S.)                                                                 

                8.4 StemCells, Inc. (U.S.)                                                                              

                8.5 Organogenesis Inc.  (U.S.)                                                                    

                8.6 NuVasive, Inc. (U.S.)                                                                              

                8.7 Vericel Corporation (Genzyme) (U.S.)                                                                            

                8.8 Cytori Therapeutics Inc. (U.S.)                                                                            

                8.9 Advantagene, Inc. (U.S.)                                                                      

                8.10 Mesoblast Ltd. (Australia)                                                                  

9. Competitive Landscape                                                                                           

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                                         

                9.4 New Product Launches                                                                         

10. Expert Opinions                                                                                        

                10.1 Market Outlook                                                                     

                10.2 Investment Opportunities                                                                 

Appendix                                                                                           

                a) List of Tables                                                                

                b) List of Figures                                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Regenerative Medicines Market By Region, From 2019-2024(USD Billion)
  2. North America Regenerative Medicines Market By Product, From 2019-2024(USD Billion)
  3. North America Cell-Based Products Regenerative Medicines Market By Region, From 2019-2024(USD Billion)
  4. North America Acellular Products Regenerative Medicines Market By Region, From 2019-2024(USD Billion)
  5. North America Regenerative Medicines Market By Therapy, From 2019-2024(USD Billion)
  6. North America Cell Therapy Regenerative Medicines Market By Region, From 2019-2024(USD Billion)
  7. North America Gene Therapy Regenerative Medicines Market By Region, From 2019-2024(USD Billion)
  8. North America Tissue Engineering Regenerative Medicines Market By Region, From 2019-2024(USD Billion)
  9. North America Immunotherapy Regenerative Medicines Market By Region, From 2019-2024(USD Billion)
  10. North America Regenerative Medicines Market By Application, From 2019-2024(USD Billion)
  11. North America Orthopedic & Musculoskeletal Spine Regenerative Medicines Market By Region, From 2019-2024(USD Billion)
  12. North America Dermatology Regenerative Medicines Market By Region, From 2019-2024(USD Billion)
  13. North America Cardiovascular Regenerative Medicines Market By Region, From 2019-2024(USD Billion)
  14. North America Central Nervous System Regenerative Medicines Market By Region, From 2019-2024(USD Billion)
  15. North America Oncology Regenerative Medicines Market By Region, From 2019-2024(USD Billion)
  16. North America Diabetes Regenerative Medicines Market By Region, From 2019-2024(USD Billion)
  17. North America Other Applications of Regenerative Medicines Market By Region, From 2019-2024(USD Billion)
  18. United States Regenerative Medicines Market By Product, From 2019-2024(USD Billion)
  19. United States Regenerative Medicines Market By Therapy, From 2019-2024(USD Billion)
  20. United States Regenerative Medicines Market By Application, From 2019-2024(USD Billion)
  21. Canada Regenerative Medicines Market By Product, From 2019-2024(USD Billion)
  22. Canada Regenerative Medicines Market By Therapy, From 2019-2024(USD Billion)
  23. Canada Regenerative Medicines Market By Application, From 2019-2024(USD Billion)
  24. North America Cell-Based Products Regenerative Medicines Market By Type, From 2019-2024(USD Billion)
  25. North America Autologous Cell-Based Products Regenerative Medicines Market By Region, From 2019-2024(USD Billion)
  26. North America Allogeneic Cell-Based Products Regenerative Medicines Market By Region, From 2019-2024(USD Billion)
  27. United States Cell-Based Products Regenerative Medicines Market By Type, From 2019-2024(USD Billion)
  28. Canada Cell-Based Products Regenerative Medicines Market By Type, From 2019-2024(USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample